Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 12:03 save search
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology
Published: 2021-02-10 (Crawled : 12:03) - globenewswire.com
BPTH | News 0 d | $4.17 -0.71% -0.96% 2.1M
|
Health Technology
|
| O: 205.19%
H: 53.37%
C: -25.83%
patent granted platform grant
ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director
Published: 2021-02-18 (Crawled : 12:03) - globenewswire.com
TLSA | News | $0.6698 4.66% 4.45% 600K
|
Health Technology
|
| O: -1.25%
H: 0.51%
C: -5.82%
ASLN | News | $0.54 0.0% 26K
|
Health Technology
|
| O: -0.52%
H: 4.49%
C: -6.86%
Greenlane Partners with Last Prisoner Project to Aid in Cannabis Criminal Justice Reform
Published: 2021-01-06 (Crawled : 12:03) - globenewswire.com
GNLN | $0.6284 -4.8% -5.04% 1.1M
|
Distribution Services
|
| O: 12.39%
H: 15.83%
C: 7.21%
cannabis
Greenlane Announces Dismissal of Class Action Suit with Prejudice
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
GNLN | $0.6284 -4.8% -5.04% 1.1M
|
Distribution Services
|
| O: 0.0%
H: 27.15%
C: 20.27%
Greenlane Announces Dismissal of Remaining Securities Class Action
Published: 2021-02-09 (Crawled : 12:03) - globenewswire.com
GNLN | $0.6284 -4.8% -5.04% 1.1M
|
Distribution Services
|
| O: 0.5%
H: 19.17%
C: 18.0%
Greenlane Selected to Moderate Featured Session at SXSW Conference
Published: 2021-02-26 (Crawled : 12:03) - globenewswire.com
GNLN | $0.6284 -4.8% -5.04% 1.1M
|
Distribution Services
|
| O: -1.92%
H: 2.66%
C: -4.8%
conference
Greenlane Acquires Eyce, The World’s Leading Brand of Silicone Smoking Products
Published: 2021-03-03 (Crawled : 12:03) - globenewswire.com
GNLN | $0.6284 -4.8% -5.04% 1.1M
|
Distribution Services
|
| O: 8.58%
H: 0.48%
C: -10.81%
Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ET
Published: 2021-03-05 (Crawled : 12:03) - globenewswire.com
AQST | $4.11 -8.67% -9.49% 2.3M
|
Health Technology
|
| O: 6.4%
H: 2.0%
C: -1.78%
epinephrine drug drug delivery liver
STRATA Skin Sciences Announces CEO Transition
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
SSKN | $0.56 5.15% 4.89% 75K
|
Health Technology
|
| O: 0.55%
H: 3.26%
C: -5.98%
ceo skin leo
Xtant Medical Announces Fourth Quarter and Full Year 2020 Financial Results
Published: 2021-02-24 (Crawled : 12:03) - globenewswire.com
XTNT | $0.83 -0.86% 0.0% 120K
|
Health Technology
|
| O: -2.3%
H: 14.71%
C: 11.76%
financial results results
Big Lots To Participate In The BofA Securities 2021 Consumer And Retail Technology Conference
Published: 2021-03-09 (Crawled : 12:03) - prnewswire.com
BIG | $3.7 1.09% -1.89% 910K
|
Retail Trade
|
| O: 1.81%
H: 1.97%
C: -3.11%
Monopar Expands Clinical Team with Appointment of Laura Kelly as Director of Clinical Operations
Published: 2021-02-18 (Crawled : 12:03) - globenewswire.com
MNPR | $0.636 -6.19% -6.6% 33K
|
Health Technology
|
| O: -2.91%
H: 0.0%
C: -6.67%
Monopar Announces Issuance of Patent Covering Composition of Matter for MNPR-101 in Canada
Published: 2021-02-09 (Crawled : 12:03) - globenewswire.com
MNPR | $0.636 -6.19% -6.6% 33K
|
Health Technology
|
| O: 8.0%
H: 0.0%
C: -3.87%
patent
Akoustis to Present at the 23rd Annual Needham Virtual Growth Conference on January 11, 2021
Published: 2021-01-05 (Crawled : 12:03) - globenewswire.com
AKTS | $0.498 -2.54% -2.61% 470K
|
Electronic Technology
|
| O: 0.17%
H: 5.3%
C: 4.04%
growth annual needham
Akoustis to Webcast Investor Update Call on February 1st at 8:00 am ET
Published: 2021-01-25 (Crawled : 12:03) - globenewswire.com
AKTS | $0.498 -2.54% -2.61% 470K
|
Electronic Technology
|
| O: 2.54%
H: 13.96%
C: 7.8%
Kymera Therapeutics Announces Key 2021 Goals and Milestones to Support its Evolution into a Fully Integrated Degrader Medicines Company
Published: 2021-01-12 (Crawled : 12:03) - globenewswire.com
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: -0.37%
H: 1.68%
C: 1.04%
milestone
Kymera Therapeutics to Present at Upcoming February Investor Conferences
Published: 2021-02-04 (Crawled : 12:03) - globenewswire.com
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 2.52%
H: 0.0%
C: -5.78%
conference presentation therapeutics
Kymera Therapeutics Strengthens Leadership with Key Appointments and Promotions
Published: 2021-02-03 (Crawled : 12:03) - globenewswire.com
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.1%
H: 15.51%
C: 13.6%
therapeutics
Kymera Therapeutics to Present at Upcoming March Investor Conferences
Published: 2021-02-25 (Crawled : 12:03) - globenewswire.com
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.8%
H: 2.65%
C: -3.97%
conference presentation therapeutics
Kymera Therapeutics Announces First-in-Human Dose in Phase 1 Trial of KT-474, a First-in-Class IRAK4 Protein Degrader to Treat Immune-Inflammatory Diseases
Published: 2021-03-02 (Crawled : 12:03) - globenewswire.com
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.0%
H: 3.09%
C: -3.3%
disease phase 1 trial phase 3 phase 2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.